Lung Marker Market Size Worth US$ 665.6 Million Globally by 2027, at 11.95% CAGR

According to the latest report by IMARC Group, titled "Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global lung marker market size reached US$ 349.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 665.6 Million by 2027, exhibiting a growth rate (CAGR) of 11.95% during 2022-2027.

Lung markers are substances produced by tumor cells that are used for lung localization. They are produced in the body in response to cancer and are found in the urine, blood and stool of the patients. They are used during lung intervention procedures for providing information regarding the nature and condition of cancer. They also aid in diagnosing, predicting and monitoring the tumor for understanding the type of therapy required to treat the condition. Apart from this, they are used in numerous hospitals and other healthcare facilities in the diagnosis and treatment of pleural effusion and mesothelioma.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/lung-marker-market/requestsample

Market Trends:

The global market is primarily driven by the increasing prevalence of lung cancer and the high mortality rates associated with it. This has led the key players to heavily invest in research and development (R&D) for the introduction of an effective cure. Since lung markers form an indispensable component in lung localization, a significant increase in their demand has been registered. Along with this, there has been an increase in the occurrence of respiratory disorders on account of deteriorating air quality, unhealthy lifestyle preferences and high smoking rates among the masses. Furthermore, the growing geriatric population across the globe is vulnerable to develop acute respiratory disorders, which is propelling the demand for lung markers. Governments of several countries are also offering numerous healthcare benefits for the early diagnosis and pre-treatment of several chronic diseases, such as lung cancer, which is acting as another major growth-inducing factor.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/lung-marker-market

Competitive Landscape with Key Players:

• Abbott Laboratories
• Thermo Fisher Scientific Inc
• Agilent Technologies, Inc
• Beckman Coulter, Inc
• Fujirebio Europe N.V
• Hologic, Inc
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers
• BioSpace, Inc

Key Segmentation:

Breakup by Cancer Type:

• Non-Small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

• EGFR
• EML4-ALK
• KRAS
• BRAF
• Others

Breakup by End User:

• Hospitals
• Diagnostic Labs
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.